Phase 2a Study Examining the Safety & Efficacy of BOL-DP-o-04 for Treating

Status Terminated

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

Clinical Trial Description

A Phase 2a, two-center, randomized, double-blind, placebo-controlled study in which subjects will be randomized to receive either BOL-DP-o-04 or placebo in addition to Standart of Care. The study evaluates the effect of BOL-DP-o-04 for Diabetic Neuropathy. The study includes a screening period up to three weeks followed by a 12-week treatment period ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04082000
Study type	Interventional
Source	Breath of Life International Pharma Ltd
Contact
Status	Terminated
Phase	Phase 1/Phase 2
Start date	April 15, 2019
Completion date	November 4, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04025320` - The Effect of Intraneural Facilitation Therapy on Diabetic Patients With Peripheral Neuropathy	N/A
Completed	`NCT02659007` - Less Neuropathy After Yoga- Managing Diabetic Neuropathy With Yoga	Phase 1
Completed	`NCT01953757` - A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)	N/A
Completed	`NCT01707979` - NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes	N/A
Completed	`NCT00608439` - Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy	Phase 2
Completed	`NCT00576277` - Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain	Phase 1/Phase 2
Completed	`NCT00830011` - Cognitive Behavioral Therapy for Painful Diabetic Neuropathy	N/A
Completed	`NCT00235443` - A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy	Phase 2/Phase 3
Completed	`NCT00931879` - Lovaza® and Microvascular Function in Type 2 Diabetes	Phase 4
Completed	`NCT00101426` - Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy	Phase 3
Completed	`NCT00190970` - The Effect of Ruboxistaurin on Small Fiber Function	Phase 2
Completed	`NCT00238550` - Study of CBME in the Relief of Painful Diabetic Neuropathy	Phase 2
Completed	`NCT05573685` - Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training	N/A
Recruiting	`NCT02341261` - Activity for Diabetic Polyneuropathy	N/A
Completed	`NCT01822925` - Study of DA-9801 to Treat Diabetic Neuropathy	Phase 2
Completed	`NCT01690962` - A Nutritional Intervention for Diabetic Neuropathy	N/A
Terminated	`NCT00993018` - A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy	Phase 2
Withdrawn	`NCT02315235` - The Peripheral Mobilized Mononuclear Cell-based Therapy in Patient With Diabetic Neuropathy	N/A
Completed	`NCT00496457` - Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy	Phase 2
Recruiting	`NCT02606747` - The Balance Control Mechanism of DPN Patients	N/A